Diastolic dyssynchrony is not rare in treatment-naive hypertensive patients. Male sex, magnesium levels, night-time HR, and mitral E/A are independent determinants for the impaired diastolic dyssynchrony. Antihypertensive therapy reduces both the severity and prevalence of diastolic dyssynchrony in patients with impaired diastolic dyssynchrony. Daytime HR, magnesium levels, and indications of systolic or diastolic dysfunction are independent predictors for improvements in diastolic dyssynchrony. Thus, magnesium levels, HR, and diastolic dysfunction seem to have important implications for diastolic dyssynchrony in hypertensive patients, whereas left ventricular hypertrophy, office BPs, arterial stiffness, central BPs, and ABPM parameters do not.
Background and ObjectivesPlacement of drug-eluting stents (DES) can be complicated by stent thrombosis; prophylactic antiplatelet therapy has been used to prevent such events. We evaluated the efficacy of cilostazol with regard to stent thrombosis as adjunctive antiplatelet therapy.Subjects and MethodsA total of 1,315 patients (846 males, 469 females) were prospectively enrolled and analyzed for the frequency of stent thrombosis. Patients with known risk factors for stent thrombosis, except diabetes and acute coronary syndrome, were excluded from the study. All patients maintained antiplatelet therapy for at least six months. To evaluate the effects of cilostazol as another option for antiplatelet therapy, triple antiplatelet therapy (aspirin+clopidogrel+cilostazol, n=502) was compared to dual antiplatelet therapy (aspirin+clopidogrel, n=813). Six months after stent placement, all patients received only two antiplatelet drugs: treatment either with cilostazol+aspirin (cilostazol group) or clopidogrel+aspirin (clopidogrel group). There were 1,033 patients (396 in cilostazol group and 637 in clopidogrel group) that maintained antiplatelet therapy for at least 12 months and were included in this study. Stent thrombosis was defined and classified according to the definition reported by the Academic Research Consortium (ARC).Resultsdefined and classified according to the definition reported by the Academic Research Consortium (ARC). Results: During follow-up (561.7±251.4 days), 15 patients (1.14%) developed stent thrombosis between day 1 to day 657. Stent thrombosis occurred in seven patients (1.39%) on triple antiplatelet therapy and four patients (0.49%) on dual antiplatelet therapy (p=NS) within the first six months after stenting. Six months and later, after stent implantation, one patient (0.25%) developed stent thrombosis in the cilostazol group, and three (0.47%) in the clopidogrel group (p=NS).ConclusionDuring the first six months after DES triple antiplatelet therapy may be more effective than dual antiplatelet therapy for the prevention of stent thrombosis. However, after the first six months, dual antiplatelet treatment, with aspirin and cilostazol, may have a better cost benefit ratio for the prevention of stent thrombosis.
Abstract:We studied optical and electrical properties of two-wavelength white tandem organic light-emitting diodes using red and blue materials. White fluorescent OLEDs were fabricated using Alq 3 : Rubrene (3 vol.% 5 nm) / SH-1 : BD-2 (3 vol.% 25 nm) as emitting layer (EML). White single fluorescent OLED showed maximum current efficiency of 9.7 cd/A, and tandem fluorescent OLED showed 18.2 cd/A. Commission Internationale de l'Eclairage (CIE) coordinates of single and tandem fluorescent OLEDs was (0.385, 0.435), (0.442, 0.473) at 1,000 cd/㎡, respectively. White hybrid OLEDs were fabricated using SH-1 : BD-2 (3 vol.% 10 nm) / CBP : Ir(mphmq) 2 (acac) (2 vol.% 20 nm) as EML. White single hybrid OLED showed maximum current efficiency of 7.8 cd/A, and tandem hybrid OLED showed 26.4 cd/A. Maximum current efficiency of tandem hybrid OLED was more twice as high as single OLED. CIE coordinates of single hybrid OLED was (0.315, 0.333), and tandem hybrid OLED was (0.448, 0.363) at 1,000 cd/㎡. CIE coordinates in white tandem OLEDs compared to those for single OLEDs observed red shift. This work reveals that stacked white OLED showed current efficiency improvement and red shifted emission than single OLED.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.